August 12, 2020

Julie Harper, M.D., owner and president of the Dermatology and Skin Cancer Center of Birmingham in Alabama, discusses how she approaches treating acne via virtual visits after incorporating telemedicine into her practice due to the COVID-19 pandemic.

August 12, 2020

Smartphones may provide another tool for physicians to assess acne severity in patients with darker skin types, a study shows.

August 11, 2020

Top educators in dermatology will come together to deliver CME lectures and engaging panel discussions via a premiere virtual platform. Learn more about MauiDerm Connect coming September 23-27.

August 11, 2020

Is telemedicine a useful tool to treat acne during the COVID-19 pandemic? Julie Harper, M.D., owner and president of the Dermatology and Skin Cancer Center of Birmingham in Alabama, shares her insights.

August 11, 2020

The International Skin Imaging Collaboration is an academic and industry partnership designed to facilitate the clinical application of digital skin imaging, with an initial focus on melanoma. The group is developing standards for dermatologic imaging and building a public archive of clinical and dermoscopic images for use in developing artificial intelligence diagnostic algorithms.

August 11, 2020

Experts offer insights into the inflammatory pathways involved in rosacea pathogenesis, the putative anti-inflammatory mechanisms of action of treatments for rosacea, and future therapeutic needs.

August 10, 2020

This week’s edition of The Mainstream Patient features stories about sun protection myths, hand sanitizer-induced eczema, at-home dermaplaning, anti-stress skincare, plus more.

August 10, 2020

Julie Harper, M.D., owner and president of the Dermatology and Skin Cancer Center of Birmingham in Alabama, emphasizes the importance of ensuring timely treatment of acne patients during the COVID-19 crisis.

August 10, 2020

The implementation of artificial intelligence technology in the long-term management and follow-up of acne patients may help to improve patient treatment outcomes.

August 07, 2020

ICYMI, this week we featured a new episode of The Cutaneous Connection, a hyperspectral technology company helping to investigate COVID-19-related skin findings, cannabinoid-containing products and their effects on prescription medications, plus more.

August 07, 2020

The U.S. Food and Drug Administration has approved IL-12/IL-23 inhibitor ustekinumab (Stelara, Janssen Pharmaceutical Companies of Johnson & Johnson) for treatment of moderate-to-severe plaque psoriasis in pediatric patients 6-11 years.

August 07, 2020

COVID-19 has left providers with fewer in-office visits, more telehealth appointments and, for many, reduced revenue.

August 07, 2020

In a study of more than 200 men and women, clinicians scored patients’ pigmentation taking into account how much of the face was impacted and compared scores to patients’ responses to the Skindex-16 questionnaire.